openPR Logo
Press release

Turkey Pharmaceutical Market Set to Reach $12.23 Billion by 2032, Growing at a 4.50% CAGR

09-24-2024 11:56 AM CET | Health & Medicine

Press release from: IMARC Group

Turkey Pharmaceutical Market Set to Reach $12.23 Billion

According to the latest report by IMARC Group, titled "๐“๐ฎ๐ซ๐ค๐ž๐ฒ ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐›๐ฒ ๐“๐ฒ๐ฉ๐ž (๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐ƒ๐ซ๐ฎ๐ ๐ฌ, ๐๐ข๐จ๐ฅ๐จ๐ ๐ข๐œ๐ฌ), ๐๐š๐ญ๐ฎ๐ซ๐ž (๐Ž๐ซ๐ ๐š๐ง๐ข๐œ, ๐‚๐จ๐ง๐ฏ๐ž๐ง๐ญ๐ข๐จ๐ง๐š๐ฅ), ๐š๐ง๐ ๐‘๐ž๐ ๐ข๐จ๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’-๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ," the report presents a thorough review featuring the Turkey Pharmaceutical Market growth, share, trends, and research of the industry.

The Turkey pharmaceutical market size reached US$ 7.81 Billion in 2023. Looking forward, IMARC Group expects the market to reach ๐”๐’$ ๐Ÿ๐Ÿ.๐Ÿ๐Ÿ‘ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง by 2032, exhibiting a growth rate (๐‚๐€๐†๐‘) ๐จ๐Ÿ ๐Ÿ’.๐Ÿ“๐ŸŽ% during 2024-2032.

The Turkey pharmaceutical market is expanding rapidly, owing to several interconnected factors. Primarily, the developing healthcare industry and expanding population of the country are the main drivers of the market, driving up demand for pharmaceuticals and other healthcare supplies. Besides this, the focus of the government bodies on expanding healthcare accessibility and infrastructure is one of the main forces behind the increase in regional pharmaceutical investment and manufacturing.

In line with these factors, the rising incidences of chronic diseases such as diabetes, cardiovascular disorders, and cancer are further fueling the need for affordable and effective pharmaceutical solutions, driving the growth of the Turkey pharmaceutical market. Additionally, Turkey is also becoming a hub for generic drug manufacturing, catering to both domestic and international markets.

๐…๐จ๐ซ ๐š๐ง ๐ข๐ง-๐๐ž๐ฉ๐ญ๐ก ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ, ๐˜๐จ๐ฎ ๐‚๐š๐ง ๐‘๐ž๐Ÿ๐ž๐ซ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.imarcgroup.com/turkey-pharmaceutical-market/requestsample

๐“๐ฎ๐ซ๐ค๐ž๐ฒ ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ & ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ:

The increasing focus on research and development (R&D) and innovation is the major factor propelling the growth of the Turkey pharmaceutical market. Moreover, local and international companies are investing heavily in the development of biologics, biosimilars, and specialty medicines to address complex health conditions. In addition to these factors, the market is also witnessing a shift towards digital healthcare solutions and e-pharmacies, making medicines highly accessible.

Furthermore, with Turkey's strategic location, the country is emerging as a key player in pharmaceutical exports, particularly to Europe, the Middle East, and Africa. These factors, along with government initiatives supporting domestic pharmaceutical production, are expected to drive the growth of the Turkey pharmaceutical market in the coming years.

๐“๐ฎ๐ซ๐ค๐ž๐ฒ ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง:

The report provides an analysis of the key trends in each segment of the market, along with forecasts at the country levels for 2024-2032. The market has categorized based on type and nature.

๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐›๐ฒ ๐“๐ฒ๐ฉ๐ž ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ:

โ€ข Pharmaceutical Drugs
o Cardiovascular Drugs
o Dermatology Drugs
o Gastrointestinal Drugs
o Genito-Urinary Drugs
o Hematology Drugs
o Anti-Infective Drugs
o Metabolic Disorder Drugs
o Musculoskeletal Disorder Drugs
o Central Nervous System Drugs
o Oncology Drugs
o Ophthalmology Drugs
o Respiratory Diseases Drugs
โ€ข Biologics
o Monoclonal Antibodies (MAbS)
o Therapeutic Proteins
o Vaccines

๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐›๐ฒ ๐๐š๐ญ๐ฎ๐ซ๐ž ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ:

โ€ข Organic
โ€ข Conventional

๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐›๐ฒ ๐‘๐ž๐ ๐ข๐จ๐ง:

โ€ข Marmara
โ€ข Central Anatolia
โ€ข Mediterranean
โ€ข Aegean
โ€ข Southeastern Anatolia
โ€ข Blacksea
โ€ข Eastern Anatolia

๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐จ๐ซ ๐‹๐š๐ง๐๐ฌ๐œ๐š๐ฉ๐ž:

The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.

๐’๐ฉ๐ž๐š๐ค ๐ญ๐จ ๐š๐ง ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ญ ๐จ๐ซ ๐€๐ง๐ฒ ๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ฒ ๐๐ž๐Ÿ๐จ๐ซ๐ž ๐๐ฎ๐ฒ๐ข๐ง๐  ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.imarcgroup.com/request?type=report&id=24198&flag=C

๐Š๐ž๐ฒ ๐ก๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:

โ€ข COVID-19 Impact on the Market
โ€ข Porter's Five Forces Analysis
โ€ข Strategic Recommendations
โ€ข Market Dynamics
โ€ข Historical, Current and Future Market Trends
โ€ข Market Drivers and Success Factors
โ€ข SWOT Analysis
โ€ข Value Chain Analysis
โ€ข Comprehensive Mapping of the Competitive Landscape
โ€ข Top Winning Strategies
โ€ข Recent Industry News
โ€ข Key Technological Trends & Development

๐๐จ๐ญ๐ž: ๐ˆ๐Ÿ ๐ฒ๐จ๐ฎ ๐ง๐ž๐ž๐ ๐ฌ๐ฉ๐ž๐œ๐ข๐Ÿ๐ข๐œ ๐ข๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง ๐ญ๐ก๐š๐ญ ๐ข๐ฌ ๐ง๐จ๐ญ ๐œ๐ฎ๐ซ๐ซ๐ž๐ง๐ญ๐ฅ๐ฒ ๐ฐ๐ข๐ญ๐ก๐ข๐ง ๐ญ๐ก๐ž ๐ฌ๐œ๐จ๐ฉ๐ž ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ, ๐ฐ๐ž ๐œ๐š๐ง ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐ž ๐ข๐ญ ๐ญ๐จ ๐ฒ๐จ๐ฎ ๐š๐ฌ ๐š ๐ฉ๐š๐ซ๐ญ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐œ๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง.

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ

๐ˆ๐Œ๐€๐‘๐‚ ๐†๐ซ๐จ๐ฎ๐ฉ
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800 | Americas: +1 631 791 1145

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services.

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Turkey Pharmaceutical Market Set to Reach $12.23 Billion by 2032, Growing at a 4.50% CAGR here

News-ID: 3665631 • Views: โ€ฆ

More Releases from IMARC Group

Turkey E-Commerce Market Share & Growth Trends 2024-2032: Industry Size, Future Outlook, and Research Report
Turkey E-Commerce Market Share & Growth Trends 2024-2032: Industry Size, Future โ€ฆ
According to the latest report by IMARC Group, titled "๐“๐ฎ๐ซ๐ค๐ž๐ฒ ๐„-๐œ๐จ๐ฆ๐ฆ๐ž๐ซ๐œ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐›๐ฒ ๐“๐ฒ๐ฉ๐ž (๐‡๐จ๐ฆ๐ž ๐€๐ฉ๐ฉ๐ฅ๐ข๐š๐ง๐œ๐ž๐ฌ, ๐€๐ฉ๐ฉ๐š๐ซ๐ž๐ฅ, ๐…๐จ๐จ๐ญ๐ฐ๐ž๐š๐ซ ๐š๐ง๐ ๐€๐œ๐œ๐ž๐ฌ๐ฌ๐จ๐ซ๐ข๐ž๐ฌ, ๐๐จ๐จ๐ค๐ฌ, ๐‚๐จ๐ฌ๐ฆ๐ž๐ญ๐ข๐œ๐ฌ, ๐†๐ซ๐จ๐œ๐ž๐ซ๐ข๐ž๐ฌ, ๐š๐ง๐ ๐Ž๐ญ๐ก๐ž๐ซ๐ฌ), ๐“๐ซ๐š๐ง๐ฌ๐š๐œ๐ญ๐ข๐จ๐ง (๐๐ฎ๐ฌ๐ข๐ง๐ž๐ฌ๐ฌ-๐ญ๐จ-๐‚๐จ๐ง๐ฌ๐ฎ๐ฆ๐ž๐ซ, ๐๐ฎ๐ฌ๐ข๐ง๐ž๐ฌ๐ฌ-๐ญ๐จ-๐๐ฎ๐ฌ๐ข๐ง๐ž๐ฌ๐ฌ, ๐‚๐จ๐ง๐ฌ๐ฎ๐ฆ๐ž๐ซ-๐ญ๐จ-๐‚๐จ๐ง๐ฌ๐ฎ๐ฆ๐ž๐ซ, ๐š๐ง๐ ๐Ž๐ญ๐ก๐ž๐ซ๐ฌ), ๐š๐ง๐ ๐‘๐ž๐ ๐ข๐จ๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’-๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ," the report presents a thorough review featuring the Turkey E-commerce Market growth, share, trends, and research of the industry. The Turkey e-commerce market size reached ๐”๐’๐ƒ ๐Ÿ๐Ÿ•.๐Ÿ– ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง in 2023. Looking forward, IMARC Group expects theโ€ฆ
Quartz Market is Expected to Reach USD 12.2 Billion by 2032, Grow at a CAGR Of 5.23%
Quartz Market is Expected to Reach USD 12.2 Billion by 2032, Grow at a CAGR Of 5 โ€ฆ
๐†๐ฅ๐จ๐›๐š๐ฅ ๐๐ฎ๐š๐ซ๐ญ๐ณ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ญ๐š๐ญ๐ข๐ฌ๐ญ๐ข๐œ๐ฌ: ๐”๐’๐ƒ ๐Ÿ๐Ÿ.๐Ÿ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐•๐š๐ฅ๐ฎ๐ž ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ ๐’๐ฎ๐ฆ๐ฆ๐š๐ซ๐ฒ: โ— The global quartz market size reached USD 7.6 Billion in 2023. โ— The market is expected to reach USD 12.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.23% during 2024-2032. โ— Asia Pacific leads the market, accounting for the largest quartz market share. โ— The increasing use of quartz in construction, especially for countertops, flooring, and other interior surfaces, is drivingโ€ฆ
Healthy Snacks Market Size is Estimated to Reach USD 139.5 Billion by 2032 with 5.46% CAGR
Healthy Snacks Market Size is Estimated to Reach USD 139.5 Billion by 2032 with โ€ฆ
๐†๐ฅ๐จ๐›๐š๐ฅ ๐‡๐ž๐š๐ฅ๐ญ๐ก๐ฒ ๐’๐ง๐š๐œ๐ค๐ฌย ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ญ๐š๐ญ๐ข๐ฌ๐ญ๐ข๐œ๐ฌ: ๐”๐’๐ƒ ๐Ÿ๐Ÿ‘๐Ÿ—.๐Ÿ“ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐•๐š๐ฅ๐ฎ๐ž ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ ๐‡๐ž๐š๐ฅ๐ญ๐ก๐ฒ ๐’๐ง๐š๐œ๐ค๐ฌ ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐’๐ฎ๐ฆ๐ฆ๐š๐ซ๐ฒ: โ— The global healthy snacks market size reached USD 86.4 Billion in 2023. โ— The market is expected to reach USD 139.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5.46% during 2024-2032. โ— North America leads the market, accounting for the largest healthy snacks market share. โ— Nuts, seeds and trail mixes account for the majority of the market shareโ€ฆ
Automotive Wiring Harness Market Size to Hit USD 115.9 Billion by 2032 | With a 3.6% CAGR
Automotive Wiring Harness Market Size to Hit USD 115.9 Billion by 2032 | With a โ€ฆ
IMARC Group's report titled "Automotive Wiring Harness Market Report by Application (Body Wiring Harness, Engine Wiring Harness, Chassis Wiring Harness, HVAC Wiring Harness, Sensors Wiring Harness, and Others), Material Type (Copper, Aluminum, and Others), Transmission Type (Data Transmission, Electrical Wiring), Vehicle Type (Two Wheelers, Passenger Cars, Commercial Vehicles), Category (General Wires, Heat Resistant Wires, Shielded Wires, Tubed Wires), Component (Connectors, Wires, Terminals, and Others), and Region 2024-2032". The global automotiveโ€ฆ

All 5 Releases


More Releases for Drugs

Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob โ€ฆ
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venousโ€ฆ
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re โ€ฆ
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplicationโ€ฆ
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastestโ€ฆ
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information: https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html Epilepsy is a chronic disease in which patientโ€™s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$โ€ฆ
Prospect of Global Excipients Market Research Report 2017 with Application inclu โ€ฆ
ResearchMoz added Latest Research Report titled " Global Excipients Market Research Report 2017 " to it's Large Report database. In this report, the global Excipients market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD),โ€ฆ
Drugs research: Misuse by shareholders of the drugs industry
A new textbook illustrates the complex and multi-faceted dimensions of evidence building in European drugs research. On one level, the authors have identified practical and philosophical challenges regarding knowledge production including, for example, measurements of the drugs problem; researching the online world; and interpreting on-site drug tests. On another level, the authors have highlighted challenges regarding knowledge production such as the misuse of evidence by knowledge brokers and policymakers.โ€ฆ